Between Approval & Execution: Early-Stage Innovation, Investment Strategy & the Future of Cancer Vaccines
Time: 3:30 pm
day: Conference Day Two
Details:
• Understanding the unique funding challenges faced by early-stage biotech developing personalized cancer vaccines to safeguard investment success
• How to position platforms and pipelines to appeal to strategic investors and VC groups amid capital scarcity
